Barriers to lifestyle modification in patients with non-alcoholic fatty liver disease: a scoping review.

Kaoru Shibayama, Chie Furushima, Minako Saka, Takako Sakamoto, Hirokazu Takahashi
Author Information
  1. Kaoru Shibayama: Institute of Nursing, Faculty of Medicine, Saga University, Japan.
  2. Chie Furushima: Institute of Nursing, Faculty of Medicine, Saga University, Japan.
  3. Minako Saka: Department of Nursing, School of Nursing at Narita, International University of Health and Welfare, Japan.
  4. Takako Sakamoto: Institute of Nursing, Faculty of Medicine, Saga University, Japan.
  5. Hirokazu Takahashi: Division of Metabolism and Endocrinology, Faculty of Medicine, Saga University, Japan.

Abstract

Non-alcoholic fatty liver disease is common worldwide, and lifestyle modifications are key to its treatment. This study aimed to identify the barriers to lifestyle modifications in patients with Non-alcoholic fatty liver disease and to organize the results using the Capability Opportunity Motivation-Behavior (COM-B) model. The framework of Arksey and O' Malley was used in this scoping review. We searched PubMed, Scopus, and the Cochrane Library without language restrictions for reports published up to September 11, 2022, including peer-reviewed literature reporting barriers to lifestyle modifications in patients with Non-alcoholic fatty liver disease. Patient-reported barriers were analyzed inductively and organized into the components (capability, opportunity, and motivation) of the COM-B model. The literature search yielded 583 articles, of which seven qualitative studies, four quantitative studies, and one mixed-methods study met the inclusion criteria. Lack of time, lack of information on the diagnosis and management of Non-alcoholic fatty liver disease, negative perceptions of the prescribed exercise and diet, physical symptoms interfering with the behavior, presence of comorbidities, and lack of family cooperation were frequently reported as barriers. The results of this study may contribute to the development of appropriate care and education strategies to promote behavioral changes in patients with Non-alcoholic fatty liver disease.

Keywords

References

  1. Dig Dis Sci. 2021 Oct;66(10):3604-3611 [PMID: 33098023]
  2. Lancet Infect Dis. 2016 Dec;16(12):1409-1422 [PMID: 27615026]
  3. J Hepatol. 2019 Mar;70(3):531-544 [PMID: 30414863]
  4. Implement Sci. 2018 Oct 22;13(1):130 [PMID: 30348165]
  5. Lancet Gastroenterol Hepatol. 2022 Sep;7(9):851-861 [PMID: 35798021]
  6. Support Care Cancer. 2022 Jun;30(6):4591-4601 [PMID: 35032199]
  7. BMJ Open Gastroenterol. 2021 Jun;8(1): [PMID: 34193468]
  8. J Gastroenterol. 2021 Dec;56(12):1045-1061 [PMID: 34718870]
  9. Frontline Gastroenterol. 2020 Apr 07;12(2):102-107 [PMID: 33613940]
  10. Lancet Gastroenterol Hepatol. 2021 Nov;6(11):903-913 [PMID: 34555346]
  11. Ann Intern Med. 2018 Oct 2;169(7):467-473 [PMID: 30178033]
  12. BMC Public Health. 2022 Nov 1;22(1):2004 [PMID: 36319982]
  13. Int J Nurs Pract. 2016 Jun;22 Suppl 2:3-11 [PMID: 27476494]
  14. BMJ Open Gastroenterol. 2021 Jul;8(1): [PMID: 34326098]
  15. Glob Health Med. 2021 Oct 31;3(5):343-350 [PMID: 34782878]
  16. Gastroenterology. 2015 Aug;149(2):367-78.e5; quiz e14-5 [PMID: 25865049]
  17. Phys Ther. 2021 Feb 4;101(2): [PMID: 33104787]
  18. JHEP Rep. 2019 Nov 05;1(6):468-479 [PMID: 32039399]
  19. Hepatol Commun. 2022 Feb;6(2):334-344 [PMID: 34697917]
  20. Dig Dis Sci. 2016 May;61(5):1365-74 [PMID: 27052013]
  21. Hisp Health Care Int. 2022 Sep;20(3):171-178 [PMID: 34658280]
  22. J Hum Nutr Diet. 2023 Jun;36(3):592-602 [PMID: 35962482]
  23. Gastroenterology. 2020 May;158(7):1984-1998.e3 [PMID: 32061596]
  24. Clin Gastroenterol Hepatol. 2019 Jun;17(7):1364-1371.e3 [PMID: 30391437]
  25. PLoS One. 2018 Oct 18;13(10):e0204890 [PMID: 30335780]
  26. Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102138 [PMID: 34186359]
  27. Implement Sci. 2011 Apr 23;6:42 [PMID: 21513547]
  28. Liver Int. 2022 Apr;42(4):820-828 [PMID: 35152526]
  29. PLoS One. 2022 Feb 17;17(2):e0263931 [PMID: 35176096]
  30. Gastroenterology. 2021 Feb;160(3):912-918 [PMID: 33307021]
  31. Obesity (Silver Spring). 2014 Sep;22(9):1973-80 [PMID: 24942930]
  32. World J Gastroenterol. 2018 Aug 14;24(30):3361-3373 [PMID: 30122876]
  33. BMJ Open Gastroenterol. 2017 Jun 1;4(1):e000139 [PMID: 28761689]
  34. Transl Behav Med. 2020 Oct 8;10(4):1016-1030 [PMID: 31120519]
  35. Nurs Open. 2021 Nov;8(6):3135-3142 [PMID: 34405583]
  36. J Hepatol. 2018 Nov;69(5):1155-1163 [PMID: 30290973]
  37. Clin Gastroenterol Hepatol. 2017 Dec;15(12):1968-1971 [PMID: 28624648]
  38. Health Expect. 2023 Feb;26(1):355-365 [PMID: 36385729]

Word Cloud

Created with Highcharts 10.0.0fattyliverdiseasenon-alcoholiclifestylebarrierspatientsmodificationsstudyCOM-BmodelresultsCapabilityOpportunityMotivation-BehaviorscopingreviewliteraturestudieslackNon-alcoholiccommonworldwidekeytreatmentaimedidentifyorganizeusingframeworkArkseyO'MalleyusedsearchedPubMedScopusCochraneLibrarywithoutlanguagerestrictionsreportspublishedSeptember112022includingpeer-reviewedreportingPatient-reportedanalyzedinductivelyorganizedcomponentscapabilityopportunitymotivationsearchyielded583articlessevenqualitativefourquantitativeonemixed-methodsmetinclusioncriteriaLacktimeinformationdiagnosismanagementnegativeperceptionsprescribedexercisedietphysicalsymptomsinterferingbehaviorpresencecomorbiditiesfamilycooperationfrequentlyreportedmaycontributedevelopmentappropriatecareeducationstrategiespromotebehavioralchangesBarriersmodificationdisease:

Similar Articles

Cited By (1)